Synergy of Trimethoprim-sulfamethoxazole

Overview

Journal Can Med Assoc J

Specialty General Medicine

Date 1975 Jun 14

PMID 1093654

Citations 17

Authors

S R Bushby

Affiliations

Soon will be listed here.

Citing Articles

Clinical Pharmacist Involved in the Treatment of Pneumonia: A Case Report.

Lai F, Huang X, Peng J, He N, Cao Z, Wu Y Infect Drug Resist. 2024; 17:5001-5010.

PMID: 39554471 PMC: 11566582. DOI: 10.2147/IDR.S477404.

Nocardia keratitis presenting as an anterior chamber ball of exudates and its management.

Bellala M, Tandra P, Bagga B, Madduri B BMJ Case Rep. 2023; 16(2).

PMID: 36810335 PMC: 9945109. DOI: 10.1136/bcr-2022-251647.

Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim-sulfamethoxazole.

McCutcheon J, Lin A, Dennis J Sci Rep. 2022; 12(1):10299.

PMID: 35717537 PMC: 9206674. DOI: 10.1038/s41598-022-14025-z.

Optimization of 2-Acylaminocycloalkylthiophene Derivatives for Activity against RnpA.

Chojnacki M, Cao X, Flaherty D, Dunman P Antibiotics (Basel). 2021; 10(4).

PMID: 33807357 PMC: 8066339. DOI: 10.3390/antibiotics10040369.

Artificial Activation of and Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy.

Rownicki M, Pienko T, Czarnecki J, Kolanowska M, Bartosik D, Trylska J Front Microbiol. 2018; 9:2870.

PMID: 30534121 PMC: 6275173. DOI: 10.3389/fmicb.2018.02870.

References

Bushby S . Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973; 128:Suppl:442-62 p. DOI: 10.1093/infdis/128.supplement_3.s442. View

Angehrn P, Then R . Nature of trimethoprim-induced death in Escherichia coli. Arzneimittelforschung. 1973; 23(3):447-51. View

Barker J, Healing D, HUTCHISON J . Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients. J Clin Pathol. 1972; 25(12):1086-8. PMC: 477627. DOI: 10.1136/jcp.25.12.1086. View

Jobanputra R, Datta N . Trimethoprim R factors in enterobacteria from clinical specimens. J Med Microbiol. 1974; 7(2):169-77. DOI: 10.1099/00222615-7-2-169. View

Anderson J, Lacey R, Lewis E, Sellin M . Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection. J Clin Pathol. 1974; 27(8):619-22. PMC: 475414. DOI: 10.1136/jcp.27.8.619. View

Nakhla L . Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim. J Clin Pathol. 1972; 25(8):708-12. PMC: 477483. DOI: 10.1136/jcp.25.8.708. View

HUNTER I . Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections. Med J Aust. 1972; 1(9):442. View

LEBEK G . [Extra-chromosomal, transmissible antibiotic resistance in human pathogens]. Hippokrates. 1972; 43(1):45-60. View

HITCHINGS G . Folate antagonists as antibacterial and antiprotozoal agents. Ann N Y Acad Sci. 1971; 186:444-51. DOI: 10.1111/j.1749-6632.1971.tb31171.x. View

10.

Koch A, BURCHALL J . Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol. 1971; 22(5):812-7. PMC: 376424. DOI: 10.1128/am.22.5.812-817.1971. View

11.

Bushby S, HITCHINGS G . Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968; 33(1):72-90. PMC: 1570262. DOI: 10.1111/j.1476-5381.1968.tb00475.x. View

12.

DARRELL J, GARROD L, Waterworth P . Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968; 21(2):202-9. PMC: 473737. DOI: 10.1136/jcp.21.2.202. View

13.

STACEY K, Simson E . IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI. J Bacteriol. 1965; 90:554-5. PMC: 315681. DOI: 10.1128/jb.90.2.554-555.1965. View

14.

Roth B, FALCO E, HITCHINGS G, Bushby S . 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO. J Med Pharm Chem. 1962; 5:1103-23. DOI: 10.1021/jm01241a004. View

15.

Brown G . The biosynthesis of folic acid. II. Inhibition by sulfonamides. J Biol Chem. 1962; 237:536-40. View

16.

BURCHALL J, HITCHINGS G . Inhibitor binding analysis of dihydrofolate reductases from various species. Mol Pharmacol. 1965; 1(2):126-36. View

17.

Fruensgaard K, KORNER B . Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections. Chemotherapy. 1974; 20(2):97-101. DOI: 10.1159/000221797. View

18.

Bushby S . Sensitivity testing with trimethorpim-sulphamethoxazole. Med J Aust. 1973; 1(2):Suppl:10-8. View

19.

Then R, Angehrn P . The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo--I. Action of sulfonamides and trimethoprim in blood and urine. Biochem Pharmacol. 1974; 23(21):2977-82. DOI: 10.1016/0006-2952(74)90272-x. View

20.

Lewis E, Lacey R . Present significance of resistance to trimethoprim and sulphonamides in coliforms, Staphylococcus aureus, and Streptococcus faecalis. J Clin Pathol. 1973; 26(3):175-80. PMC: 477680. DOI: 10.1136/jcp.26.3.175. View